Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. (4595.T) Stock Competitors & Peer Comparison
See (4595.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4595.T | ¥1,759.00 | -0.73% | 33.5B | 9.78 | ¥179.87 | +5.68% |
| 4502.T | ¥5,310.00 | +0.76% | 8.3T | 74.07 | ¥70.73 | +3.82% |
| 4507.T | ¥3,151.00 | -0.60% | 2.7T | 15.58 | ¥200.82 | +2.27% |
| 4523.T | ¥4,700.00 | +0.28% | 1.3T | 26.81 | ¥174.86 | +3.41% |
| 4581.T | ¥8,580.00 | -0.12% | 703.3B | 83.43 | ¥102.84 | N/A |
| 4506.T | ¥1,657.00 | -3.63% | 687.1B | 4.44 | ¥389.48 | N/A |
| 4530.T | ¥6,040.00 | +0.00% | 425.2B | 22.47 | ¥268.78 | +1.99% |
| 4516.T | ¥4,793.00 | +0.06% | 322.2B | 10.08 | ¥474.18 | +2.59% |
| 8129.T | ¥4,433.00 | -0.92% | 281.6B | 14.45 | ¥301.23 | +3.79% |
| 4540.T | ¥3,628.00 | -0.63% | 270.6B | 9.99 | ¥363.36 | +3.97% |
Stock Comparison
4595.T vs 4502.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4502.T has a market cap of 8.3T. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4502.T trades at ¥5,310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4502.T's P/E ratio is 74.07. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4502.T's ROE of +0.02%. Regarding short-term risk, 4595.T is less volatile compared to 4502.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4502.T's competition here
4595.T vs 4507.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4507.T has a market cap of 2.7T. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4507.T trades at ¥3,151.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4507.T's P/E ratio is 15.58. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4507.T's ROE of +0.14%. Regarding short-term risk, 4595.T is less volatile compared to 4507.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4507.T's competition here
4595.T vs 4523.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4523.T has a market cap of 1.3T. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4523.T trades at ¥4,700.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4523.T's P/E ratio is 26.81. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4523.T's ROE of +0.05%. Regarding short-term risk, 4595.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4523.T's competition here
4595.T vs 4581.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4581.T has a market cap of 703.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4581.T trades at ¥8,580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4581.T's ROE of +0.02%. Regarding short-term risk, 4595.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4581.T's competition here
4595.T vs 4506.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4506.T has a market cap of 687.1B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4506.T trades at ¥1,657.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4506.T's P/E ratio is 4.44. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4506.T's ROE of +0.49%. Regarding short-term risk, 4595.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4506.T's competition here
4595.T vs 4530.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4530.T has a market cap of 425.2B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4530.T trades at ¥6,040.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4530.T's P/E ratio is 22.47. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4530.T's ROE of +0.07%. Regarding short-term risk, 4595.T is more volatile compared to 4530.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4530.T's competition here
4595.T vs 4516.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4516.T has a market cap of 322.2B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4516.T trades at ¥4,793.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4516.T's P/E ratio is 10.08. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4516.T's ROE of +0.11%. Regarding short-term risk, 4595.T is less volatile compared to 4516.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4516.T's competition here
4595.T vs 8129.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 8129.T has a market cap of 281.6B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 8129.T trades at ¥4,433.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 8129.T's P/E ratio is 14.45. In terms of profitability, 4595.T's ROE is +0.20%, compared to 8129.T's ROE of +0.09%. Regarding short-term risk, 4595.T is less volatile compared to 8129.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 8129.T's competition here
4595.T vs 4540.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4540.T has a market cap of 270.6B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4540.T trades at ¥3,628.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4540.T's P/E ratio is 9.99. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4540.T's ROE of +0.10%. Regarding short-term risk, 4595.T is less volatile compared to 4540.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4540.T's competition here
4595.T vs 4887.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4887.T has a market cap of 238.6B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4887.T trades at ¥2,135.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4887.T's P/E ratio is 21.32. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4887.T's ROE of -0.02%. Regarding short-term risk, 4595.T is less volatile compared to 4887.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4887.T's competition here
4595.T vs 4553.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4553.T has a market cap of 194.9B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4553.T trades at ¥3,980.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4553.T's P/E ratio is 9.44. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4553.T's ROE of +0.12%. Regarding short-term risk, 4595.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4553.T's competition here
4595.T vs 4547.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4547.T has a market cap of 179.1B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4547.T trades at ¥4,360.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4547.T's P/E ratio is 12.63. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4547.T's ROE of +0.07%. Regarding short-term risk, 4595.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4547.T's competition here
4595.T vs 4551.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4551.T has a market cap of 178.5B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4551.T trades at ¥6,350.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4551.T's P/E ratio is 33.00. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4551.T's ROE of +0.03%. Regarding short-term risk, 4595.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4551.T's competition here
4595.T vs 4521.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4521.T has a market cap of 154.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4521.T trades at ¥4,050.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4521.T's P/E ratio is 285.76. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4521.T's ROE of -0.03%. Regarding short-term risk, 4595.T is less volatile compared to 4521.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4521.T's competition here
4595.T vs 4534.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4534.T has a market cap of 119.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4534.T trades at ¥3,430.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4534.T's P/E ratio is 17.76. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4534.T's ROE of +0.05%. Regarding short-term risk, 4595.T is less volatile compared to 4534.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4534.T's competition here
4595.T vs 4559.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4559.T has a market cap of 94B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4559.T trades at ¥2,135.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4559.T's P/E ratio is 16.75. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4559.T's ROE of +0.08%. Regarding short-term risk, 4595.T is less volatile compared to 4559.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4559.T's competition here
4595.T vs 4569.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4569.T has a market cap of 87.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4569.T trades at ¥1,543.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4569.T's P/E ratio is 9.41. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4569.T's ROE of +0.08%. Regarding short-term risk, 4595.T is less volatile compared to 4569.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4569.T's competition here
4595.T vs 4886.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4886.T has a market cap of 82.2B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4886.T trades at ¥2,879.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4886.T's P/E ratio is 17.21. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4886.T's ROE of +0.07%. Regarding short-term risk, 4595.T is less volatile compared to 4886.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4886.T's competition here
4595.T vs 4554.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4554.T has a market cap of 52.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4554.T trades at ¥2,232.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4554.T's P/E ratio is 17.51. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4554.T's ROE of +0.05%. Regarding short-term risk, 4595.T is less volatile compared to 4554.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4554.T's competition here
4595.T vs 4577.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4577.T has a market cap of 36.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4577.T trades at ¥1,244.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4577.T's P/E ratio is 16.75. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4577.T's ROE of +0.06%. Regarding short-term risk, 4595.T is less volatile compared to 4577.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4577.T's competition here
4595.T vs 9273.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 9273.T has a market cap of 36.1B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 9273.T trades at ¥875.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 9273.T's P/E ratio is 9.81. In terms of profitability, 4595.T's ROE is +0.20%, compared to 9273.T's ROE of +0.13%. Regarding short-term risk, 4595.T is less volatile compared to 9273.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 9273.T's competition here
4595.T vs 4538.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4538.T has a market cap of 19B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4538.T trades at ¥2,231.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4538.T's P/E ratio is -4.77. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4538.T's ROE of -0.12%. Regarding short-term risk, 4595.T is more volatile compared to 4538.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4538.T's competition here
4595.T vs 2929.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 2929.T has a market cap of 18.5B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 2929.T trades at ¥623.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 2929.T's P/E ratio is -10.92. In terms of profitability, 4595.T's ROE is +0.20%, compared to 2929.T's ROE of -0.16%. Regarding short-term risk, 4595.T is less volatile compared to 2929.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 2929.T's competition here
4595.T vs 4574.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4574.T has a market cap of 14.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4574.T trades at ¥293.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4574.T's P/E ratio is 15.90. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4574.T's ROE of +0.11%. Regarding short-term risk, 4595.T is less volatile compared to 4574.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4574.T's competition here
4595.T vs 4512.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4512.T has a market cap of 12.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4512.T trades at ¥362.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4512.T's P/E ratio is 169.71. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4512.T's ROE of +0.03%. Regarding short-term risk, 4595.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4512.T's competition here
4595.T vs 4524.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4524.T has a market cap of 9.1B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4524.T trades at ¥2,219.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4524.T's P/E ratio is 15.62. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4524.T's ROE of +0.05%. Regarding short-term risk, 4595.T is more volatile compared to 4524.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4524.T's competition here
4595.T vs 4597.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4597.T has a market cap of 8.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4597.T trades at ¥32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4597.T's P/E ratio is -8.67. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4597.T's ROE of -0.62%. Regarding short-term risk, 4595.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4597.T's competition here
4595.T vs 7079.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 7079.T has a market cap of 6.3B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 7079.T trades at ¥2,612.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 7079.T's P/E ratio is 8.60. In terms of profitability, 4595.T's ROE is +0.20%, compared to 7079.T's ROE of +0.16%. Regarding short-term risk, 4595.T is less volatile compared to 7079.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 7079.T's competition here
4595.T vs 4539.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4539.T has a market cap of 6.1B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4539.T trades at ¥1,670.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4539.T's P/E ratio is 12.08. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4539.T's ROE of +0.03%. Regarding short-term risk, 4595.T is more volatile compared to 4539.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4539.T's competition here
4595.T vs 4883.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4883.T has a market cap of 5.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4883.T trades at ¥64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4883.T's P/E ratio is -2.37. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4883.T's ROE of -0.72%. Regarding short-term risk, 4595.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4883.T's competition here
4595.T vs 4892.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4892.T has a market cap of 5.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4892.T trades at ¥681.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4892.T's P/E ratio is -7.81. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4892.T's ROE of -0.30%. Regarding short-term risk, 4595.T is less volatile compared to 4892.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4892.T's competition here
4595.T vs 4586.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4586.T has a market cap of 4.7B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4586.T trades at ¥79.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4586.T's P/E ratio is -4.59. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4586.T's ROE of -0.48%. Regarding short-term risk, 4595.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4586.T's competition here
4595.T vs 4582.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4582.T has a market cap of 4.5B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4582.T trades at ¥93.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4582.T's P/E ratio is -0.95. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4582.T's ROE of -2.20%. Regarding short-term risk, 4595.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4582.T's competition here
4595.T vs 4541.T Comparison May 2026
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 33.5B. In comparison, 4541.T has a market cap of 2.5B. Regarding current trading prices, 4595.T is priced at ¥1,759.00, while 4541.T trades at ¥35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 9.78, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 4595.T's ROE is +0.20%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 4595.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4541.T's competition here